Prof Andrew Sindone
Cardiologist and Director, Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital, Australia, New South Wales
Prof Jonathan Shaw
Deputy Director at Melbourne’s Baker Heart and Diabetes Institute
Assoc Prof Christine Burdeniuk
Associate Professor Flinders University, SALHN (South Adelaide Local Health Network)
 

Role of Diagnostics: NT-proBNP in management of Heart Failure

Wednesday, 16th Nov 2022

6:30 – 7:30 pm AEDT (GMT +11) | 3:30pm – 4:30pm (GMT+8)

View other time zones

At the heart of the discussion on diabetes, this webinar will discuss the latest updates on the mangement of heart failure, particularly the importance of cardiovascular risk assessment for your type 2 diabetes mellitus patients. With the new CVD risk assessment tools available, we will have a heart-to-heart discussion with our experts as they share how these biomarker tools might best be applied to clinical practice.

We look forward to you joining us at the live webinar!

Who should attend:

Cardiologist, Endocrinologist, Pathologist, Cardiology advanced Trainees, GP’s, Geriatricians, Basic Physician trainees

Key reasons to attend:

  • To learn about the Latest advances and management of Heart failure.
  • To understand the value of NT-proBNP in clinical use.
  • To know the clinical approach of managing patients with Acute and Chronic Heart Failure.
  • To be aware on the guidelines on usage of NT-proBNP.
  • To hear from APAC Endocrinologist on real world clinical implementation of NT-proBNP in T2DM patients

Agenda

TIME

TOPIC

SPEAKERS


18:30 – 18:45
Welcome and Latest advances in Heart Failure management in Australia
Prof. Andrew Sindone

18:45 – 19:00
Early NT proBNP testing in Acute and Chronic Heart Failure
A/ Prof. Christine Burdeniuk

19:00 – 19:15
Potential role of NT proBNP as a predictor of Future risk of Heart Failure in Type 2 Diabetes Mellitus of Heart Failure
Prof. Jonathan Shaw

19:15 – 19:30
Q&A and closing
All

President of APSC Cofound of digital trends in Asia

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy.

28 March 2023
Prof Alexandre Mebazaa

CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi